1. Guerrero A, Campo LD, Piscaglia F, et al. 2023; Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. J Hepatol. 79:69–78. DOI:
10.1016/j.jhep.2023.02.023. PMID:
36858157.
2. Anton A, Campreciós G, Pérez-Campuzano V, Orts L, García-Pagán JC, Hernández-Gea V. 2022; The pathophysiology of portal vein thrombosis in cirrhosis: Getting deeper into Virchow's triad. J Clin Med. 11:800. DOI:
10.3390/jcm11030800. PMID:
35160251. PMCID:
PMC8837039.
3. Wang L, Guo X, Xu X, et al. 2021; Anticoagulation favors thrombus recanalization and survival in patients with liver cirrhosis and portal vein thrombosis: Results of a meta-analysis. Adv Ther. 38:495–520. DOI:
10.1007/s12325-020-01550-4. PMID:
33155180. PMCID:
PMC7854392.